The development of neutralizing antibodies against SARS-CoV-2 and their common features

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide severe coronavirus disease 2019 (COVID-19) pandemic since December 2019. There is a great demand for effective therapies for the prevention and treatment of COVID-19. Developing therapeutic neutralizing antibodies (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liu Daisy, Lian, Chaoyang, Yeap, Leng-Siew, Meng, Fei-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799018/
https://www.ncbi.nlm.nih.gov/pubmed/33377928
http://dx.doi.org/10.1093/jmcb/mjaa070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799018/
https://www.ncbi.nlm.nih.gov/pubmed/33377928
http://dx.doi.org/10.1093/jmcb/mjaa070

Ejemplares similares